Aurion Biotech raises $120m to advance cell therapy programme

 Aurion Biotech  has raised $120m from biotech and ophthalmology investors to progress its cell therapy programme for corneal edema secondary to endothelial dysfunction.

Related Keywords

Japan ,Kyoto ,Andrew Elbardissi ,Shigeru Kinoshita ,Raymond James ,Greg Kunst ,Patrick Lally ,Kyoto Prefecture University Of Medicine , ,Deerfield Management ,Petrichor Healthcare Capital Management ,Flyingl Partners ,Falcon Vision ,Visionary Ventures ,Aurion Biotech ,Professor Shigeru Kinoshita ,Kyoto Prefecture University ,